TFS HealthScienceExploring the Evolving Landscape of EU Clinical Trials Post-RegulationAs of February 2024, we are less than one year out from 31 January 2025, a date that marks the end of the three-year transition period…Apr 6Apr 6
TFS HealthScienceThe Role of CROs in Accelerating Drug Development for Public HealthThe theme for World Health Day 2024, reflecting that more than half the world’s population is not fully covered by essential health…Apr 6Apr 6
TFS HealthScienceWhat is a Functional Service Provider (FSP) in Clinical ResearchThe costs of drug development have been estimated to range from US$43 million all the way up to US$2.9 billion. One Phase III trial alone…Apr 6Apr 6